ATE261425T1 - Erythromycin-derivate mit antibiotischer wirkung - Google Patents

Erythromycin-derivate mit antibiotischer wirkung

Info

Publication number
ATE261425T1
ATE261425T1 AT99938386T AT99938386T ATE261425T1 AT E261425 T1 ATE261425 T1 AT E261425T1 AT 99938386 T AT99938386 T AT 99938386T AT 99938386 T AT99938386 T AT 99938386T AT E261425 T1 ATE261425 T1 AT E261425T1
Authority
AT
Austria
Prior art keywords
erythromycin derivatives
antibiotic action
erythromycin
derivatives
antibiotic
Prior art date
Application number
AT99938386T
Other languages
English (en)
Inventor
Franco Pellacini
Daniela Botta
Enrico Albini
Domenico Ungheri
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE261425T1 publication Critical patent/ATE261425T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT99938386T 1998-07-30 1999-07-27 Erythromycin-derivate mit antibiotischer wirkung ATE261425T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI001776A IT1301968B1 (it) 1998-07-30 1998-07-30 Derivati di eritromicina ad attivita' antibiotica
PCT/EP1999/005485 WO2000006606A2 (en) 1998-07-30 1999-07-27 Erythromycin derivatives with antibiotic activity

Publications (1)

Publication Number Publication Date
ATE261425T1 true ATE261425T1 (de) 2004-03-15

Family

ID=11380563

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99938386T ATE261425T1 (de) 1998-07-30 1999-07-27 Erythromycin-derivate mit antibiotischer wirkung

Country Status (8)

Country Link
US (1) US6468979B1 (de)
EP (1) EP1100762B1 (de)
AT (1) ATE261425T1 (de)
AU (1) AU5290199A (de)
DE (1) DE69915487T2 (de)
ES (1) ES2215396T3 (de)
IT (1) IT1301968B1 (de)
WO (1) WO2000006606A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6947844B2 (en) * 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) * 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
AR043050A1 (es) * 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
BRPI0408117A (pt) * 2003-03-05 2006-03-01 Rib X Pharmaceuticals Inc compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
EP1629013B1 (de) 2003-05-31 2018-01-24 Amgen Research (Munich) GmbH Pharmazeutische zusammensetzungen, die einen für epcam spezifischen bispezifischen antikörper enthalten
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
JP2007512256A (ja) * 2003-11-18 2007-05-17 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法
EP2716647A3 (de) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Makrocyclische Verbindungen Und Verfahren Zu Deren Herstellung Und Anwendung
JP2009506066A (ja) 2005-08-24 2009-02-12 リブ−エックス ファーマシューティカルズ,インコーポレイテッド トリアゾール化合物ならびにこれを作製する方法および使用する方法
WO2012052412A1 (de) 2010-10-22 2012-04-26 Bayer Cropscience Ag Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
MX2017015456A (es) * 2015-06-01 2018-11-29 Bantam Pharmaceutical Llc Compuestos de pirazol y pirrol sustituidos y metodos para su uso por inhibición de iniciación de traducción y tratamiento de enfermedades y trastornos relacionados con ellos.
MX2019006296A (es) 2016-11-30 2019-11-12 Bantam Pharmaceutical Llc Métodos de uso de compuestos de pirazol y pirazol sustituido y para el tratamiento de enfermedades hiperproliferativas.
WO2018102453A1 (en) 2016-11-30 2018-06-07 Bantam Pharmaceutical, Llc Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica

Also Published As

Publication number Publication date
IT1301968B1 (it) 2000-07-20
WO2000006606A3 (en) 2000-05-04
US6468979B1 (en) 2002-10-22
ITMI981776A1 (it) 2000-01-30
EP1100762A2 (de) 2001-05-23
ES2215396T3 (es) 2004-10-01
DE69915487T2 (de) 2005-02-17
EP1100762B1 (de) 2004-03-10
AU5290199A (en) 2000-02-21
DE69915487D1 (de) 2004-04-15
WO2000006606A2 (en) 2000-02-10
ITMI981776A0 (it) 1998-07-30

Similar Documents

Publication Publication Date Title
IL166527A0 (en) Macrolide compounds endowed with antiinflammatory activity
DE69915487D1 (de) Erythromycin-derivate mit antibiotischer wirkung
AU3091489A (en) Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
HUT58059A (en) Insecticidal composiiton and process for producing its active ingredient, 1-pyridylimidazole derivatives
PT876388E (pt) Derivados de eritromicina triciclica
CA2326222A1 (en) Medicinal compositions
DE60303967D1 (de) 9a-azalide mit entzündungshemmender wirkung
DE69222698D1 (de) 4-desoxy-4-epipodophyllotoxinderivate oder deren pharmazeutisch akzeptierbaren salze
IS2258B (is) Setin tríasóló-pýridasín afleiða, lyfjasamsetningar gerðar úr henni
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
ITMI912745A0 (it) Derivati 5h-benzodiazepinici, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
NO940844D0 (no) Farmasöytisk aktive hydroksykarboksylsyrederivater
EP1059304A4 (de) Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten
ATE254625T1 (de) Eythromycinderivat mit antibiotischer aktvität
MX9203221A (es) Compuesto farmacologicamente activo, preparacion y empleo.
DE68908838D1 (de) Pharmazeutisch wirksame Dithioketen-Derivaten.
DK1086695T3 (da) Antivirale præparater omfattende yohimbin som aktivt princip
AU5177390A (en) Pyridine derivatives and their salts, and insecticidal/acaricidal agent containing the same as active ingredient
HUP9801085A3 (en) Piperazinyl-alkyl-benzofurane derivatives, pharmaceutical compositions containing them as active ingredient and process for producing the active ingredient
ZA891583B (en) Piperazine derivative or its salt,process for producing the same and pharmaceutical composition comprising the same as active ingredient

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties